Real research from the past six months — curated for men who want to understand the circadian, ultradian, and seasonal rhythms driving testosterone, cortisol, sleep, and metabolism. Every finding in plain language and mechanistic depth.
DISCOVERY2025
The "testobolome": scientists discover gut bacteria metabolize testosterone
Parallel to the estrobolome, a 2025 NPJ Biofilms and Microbiomes paper formally defines the testobolome — gut bacteria that degrade and transform testosterone in men, with direct implications for hormone levels and male reproductive health.
BMAL1 and CLOCK: your circadian genes literally build your testosterone
A September 2025 Asian Journal of Andrology review establishes that the circadian clock proteins BMAL1 and CLOCK directly regulate testosterone synthesis in Leydig cells — and that disrupting sleep disrupts steroidogenesis at the molecular level.
A new framework for diagnosing low testosterone — timing and tissue both matter
A Journal of Urology 2025-2026 paper proposes integrating circadian thresholds and organ-specific testosterone effects into testosterone deficiency diagnosis — moving beyond the single morning total-T measurement that misses 30-40% of functional hypogonadism cases.
Ashwagandha definitively lowers cortisol — but not how stressed you feel
A 2025 meta-analysis confirms statistically significant cortisol reduction (−1.16 µg/dL) from ashwagandha, but finds no effect on perceived stress scores. The distinction matters: biological cortisol suppression and subjective stress perception are separate systems.
Breaking the nocturia-testosterone loop: sleep quality as the hidden testosterone driver
A 2025 circadian medicine study found that men with nocturia (nighttime urination) have chronically suppressed testosterone — and that relieving nocturia raises testosterone even in men with "normal" baseline levels, revealing sleep disruption as an underdiagnosed T-suppression mechanism.
GLP-1 drugs are recovering testosterone in men — often without TRT
Multiple 2025 studies confirm that GLP-1 receptor agonists (semaglutide, tirzepatide) substantially increase testosterone in men with obesity-related hypogonadism — not just through weight loss, but through direct effects on Leydig cells and the HPG axis. For men with low-normal T and metabolic issues, this changes the conversation.
Peptides for men's health: what has real evidence, what's experimental, what's hype
Growth hormone secretagogues, BPC-157, TB-500, PT-141, and more — the peptide space has exploded in men's health and fitness communities. Here's a structured breakdown of what the actual 2025 research supports, stratified by evidence quality and relevant to men's hormonal and metabolic health.
Helian Research Dispatch is updated as significant findings emerge. All studies linked to their primary source. Helian supplements are not diagnostic tools — always work with your clinician for treatment decisions.